Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Australia's Medibank Private reports 1% net profit drop

Australia’s Medibank Private has reported a net profit of $445 million, down 1% from $449.5 million last year.

Medibank_small
Source: Medibank

Medibank Australia reports its net profit drop was due to lower equity and credit market returns.

Medibank's net investment income has decreased 3.1% to $95.6 million, with stock posts its biggest intraday fall since June 2016.

Operating profit in health insurance jumped 7.7% to $536 million, with a revenue growth of 1.2%.

While there’s been a 1% drop net income, the report shows Medibank's health insurance business seems to be turning around.

Medibank Private chief executive Craig Drummond agrees. Mr Drummond says he’s pleased with the growth progress.

'This result demonstrates that our core health insurance business is back on track and in the coming year we will continue to transform our relationship with our customers and deliver a more personalised and proactive experience.’ Said Mr Drummond.

Health insurance operating profit is reported at $535.6 million up 7.7 %, with a $38 million increase.

Another fall however, with the net investment income falling by 31.4% to $95.6 million, showing lower returns across growth and defensive portfolios.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer